Treace Medical Concepts Net Income 2020-2024 | TMCI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Treace Medical Concepts net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Treace Medical Concepts Net Income 2020-2024 | TMCI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Treace Medical Concepts net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$211B
Intuitive Surgical (ISRG)	$191.1B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.8B
Edwards Lifesciences (EW)	$39.1B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$27.3B
Waters (WAT)	$22.8B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.6B
Hologic (HOLX)	$18.3B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Globus Medical (GMED)	$11B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$5.2B
Integer Holdings (ITGR)	$4.6B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B